Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2677 |
|
Actual shortage: | 256 (10%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2412 (90%) | |
Discontinuation Reports |
250 |
|
To be discontinued: | 3 (1%) | |
Discontinued: | 247 (99%) | |
Reversed: | 0 (0%) | |
Late reports |
330 (11%) |
|
Overdue reports |
24 (9%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-TRIMEL | 40MG 8MG | SUSPENSION | Actual shortage | 2017-03-13 | 2017-10-13 | 1591 |
TEVA-TRIMEL | 400MG 80MG | TABLET | Resolved | 2017-03-13 | 2020-02-13 | 1582 |
TEVA-SPIRONOLACTONE | 25MG | TABLET | Resolved | 2017-03-13 | 2017-10-11 | 1568 |
TEVA-RISPERIDONE | 0.5MG | TABLET | Resolved | 2017-03-13 | 2023-10-03 | 1566 |
TEVA-SPIRONOLACTONE | 100MG | TABLET | Resolved | 2017-03-13 | 2020-02-13 | 1560 |
TEVA-VALSARTAN/HCTZ | 12.5MG 160MG | TABLET | Resolved | 2017-03-13 | 2017-10-10 | 1552 |
TEVA-RANITIDINE | 300MG | TABLET | Resolved | 2017-03-13 | 2020-02-13 | 1534 |
TEVA-RANITIDINE | 300MG | TABLET | Resolved | 2017-03-13 | 2020-02-13 | 1522 |
TEVA-RANITIDINE | 150MG | TABLET | Resolved | 2017-03-13 | 2020-02-13 | 1510 |
TEVA-PAROXETINE | 30MG | TABLET | Resolved | 2017-03-13 | 2017-10-10 | 1454 |
TEVA-VALSARTAN/HCTZ | 25MG 320MG | TABLET | Resolved | 2017-03-13 | 2018-05-11 | 1226 |
TEVA-PAROXETINE | 30MG | TABLET | Resolved | 2017-03-13 | 2017-10-10 | 1204 |
TEVA-PAROXETINE | 30MG | TABLET | Resolved | 2017-03-13 | 2017-10-10 | 1199 |
TEVA-PAROXETINE | 20MG | TABLET | Resolved | 2017-03-13 | 2017-10-10 | 1191 |
TEVA-PAROXETINE | 20MG | TABLET | Resolved | 2017-03-13 | 2017-10-10 | 1179 |
TEVA-PAROXETINE | 20MG | TABLET | Resolved | 2017-03-13 | 2017-10-10 | 1175 |
TEVA-PAROXETINE | 10MG | TABLET | Resolved | 2017-03-13 | 2017-10-10 | 1167 |
TEVA-PAROXETINE | 10MG | TABLET | Resolved | 2017-03-13 | 2017-10-10 | 1161 |
TEVA-PAROXETINE | 10MG | TABLET | Resolved | 2017-03-13 | 2017-10-10 | 1153 |
TEVA-NORFLOXACIN | 400MG | TABLET | Actual shortage | 2017-03-13 | 2017-10-11 | 1143 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-CLONAZEPAM | 0.5MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64923 |
NOVO-PROFEN | 400MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64920 |
RATIO-TAMSULOSIN | 0.4MG | CAPSULE (SUSTAINED-RELEASE) | Discontinued | 2018-10-19 | 2018-10-19 | 64917 |
TEVA-LISINOPRIL (TYPE P) | 5MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64909 |
RATIO-FENOFIBRATE MC | 200MG | CAPSULE | Discontinued | 2018-10-19 | 2018-10-19 | 64891 |
ACT DONEPEZIL ODT | 5MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2018-10-19 | 2018-10-19 | 64875 |
ACT DONEPEZIL ODT | 10MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2018-10-19 | 2018-10-19 | 64872 |
TEVA-ENALAPRIL | 4MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64869 |
TEVA-ENALAPRIL | 16MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64866 |
TEVA-ENALAPRIL | 8MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64861 |
TEVA-ENALAPRIL | 8MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64858 |
TEVA-ENALAPRIL | 8MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64855 |
RATIO-ATORVASTATIN | Discontinued | 2018-10-19 | 2018-10-19 | 64852 | ||
TEVA-QUETIAPINE | 25MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64849 |
TEVA-QUETIAPINE | 100MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64846 |
RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64626 | ||
RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64623 | ||
RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64615 | ||
TEVA-ATORVASTATIN | 20MG | TABLET | Discontinued | 2018-10-17 | 2018-10-17 | 64612 |
TEVA-ATORVASTATIN | 20MG | TABLET | Discontinued | 2018-10-17 | 2018-10-17 | 64609 |